Keystone Financial Group Sorrento Therapeutics, Inc. Transaction History

Keystone Financial Group

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$0.74 - $1.83 $1,517 - $3,751	2,050 Added 9.05%	24,700 $21,000
Q2 2022 Aug 05, 2022	BUY	$1.24 - $2.33 $3,100 - $5,825	2,500 Added 12.41%	22,650 $46,000
Q1 2022 May 13, 2022	BUY	$2.0 - $4.9 $4,000 - $9,800	2,000 Added 11.02%	20,150 $47,000
Q4 2021 Feb 11, 2022	BUY	$4.65 - $7.23 $4,650 - $7,230	1,000 Added 5.83%	18,150 $84,000
Q3 2021 Nov 12, 2021	BUY	$7.41 - $10.99 $741 - $1,099	100 Added 0.59%	17,150 $131,000
Q1 2021 May 11, 2021	BUY	$7.03 - $16.51 $7,592 - $17,830	1,080 Added 6.76%	17,050 $141,000
Q4 2020 Feb 10, 2021	BUY	$5.76 - $11.95 $91,987 - $190,841	15,970 New	15,970 $109,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Keystone Financial Group, based on Form 13F filings with the SEC.

Stay updated on Keystone Financial Group with notifications on news.